Assessment	B:C0220825
of	O
Early	O
Treatment	O
Response	I:C0521982
With	O
DWI	O
After	O
CT	O
-	O
Guided	O
Radiofrequency	O
Ablation	I:C0850292
of	O
Functioning	O
Adrenal	O
Adenomas	I:C0206667
.	O

Assessment	O
of	O
Early	O
Treatment	B:C0521982
Response	I:C0521982
With	O
DWI	O
After	O
CT	O
-	O
Guided	O
Radiofrequency	O
Ablation	I:C0850292
of	O
Functioning	O
Adrenal	O
Adenomas	I:C0206667
.	O

Assessment	O
of	O
Early	O
Treatment	O
Response	I:C0521982
With	O
DWI	B:C0598801
After	O
CT	O
-	O
Guided	O
Radiofrequency	O
Ablation	I:C0850292
of	O
Functioning	O
Adrenal	O
Adenomas	I:C0206667
.	O

Assessment	O
of	O
Early	O
Treatment	O
Response	I:C0521982
With	O
DWI	O
After	O
CT	B:C0040405
-	O
Guided	O
Radiofrequency	O
Ablation	I:C0850292
of	O
Functioning	O
Adrenal	O
Adenomas	I:C0206667
.	O

Assessment	O
of	O
Early	O
Treatment	O
Response	I:C0521982
With	O
DWI	O
After	O
CT	O
-	O
Guided	O
Radiofrequency	B:C0850292
Ablation	I:C0850292
of	O
Functioning	O
Adrenal	O
Adenomas	I:C0206667
.	O

Assessment	O
of	O
Early	O
Treatment	O
Response	I:C0521982
With	O
DWI	O
After	O
CT	O
-	O
Guided	O
Radiofrequency	O
Ablation	I:C0850292
of	O
Functioning	O
Adrenal	B:C0206667
Adenomas	I:C0206667
.	O

The	O
objective	O
of	O
this	O
study	B:C2603343
was	O
to	O
establish	O
the	O
suitability	O
of	O
the	O
apparent	O
diffusion	O
coefficient	O
(	O
ADC	O
)	O
as	O
a	O
parameter	O
for	O
evaluating	O
early	O
treatment	O
response	I:C0521982
after	O
percutaneous	O
ablation	O
of	O
functional	O
adrenal	O
adenomas	I:C0206667
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
establish	O
the	O
suitability	O
of	O
the	O
apparent	O
diffusion	O
coefficient	O
(	O
ADC	O
)	O
as	O
a	O
parameter	O
for	O
evaluating	O
early	O
treatment	B:C0521982
response	I:C0521982
after	O
percutaneous	O
ablation	O
of	O
functional	O
adrenal	O
adenomas	I:C0206667
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
establish	O
the	O
suitability	O
of	O
the	O
apparent	O
diffusion	O
coefficient	O
(	O
ADC	O
)	O
as	O
a	O
parameter	O
for	O
evaluating	O
early	O
treatment	O
response	I:C0521982
after	O
percutaneous	B:C0522523
ablation	O
of	O
functional	O
adrenal	O
adenomas	I:C0206667
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
establish	O
the	O
suitability	O
of	O
the	O
apparent	O
diffusion	O
coefficient	O
(	O
ADC	O
)	O
as	O
a	O
parameter	O
for	O
evaluating	O
early	O
treatment	O
response	I:C0521982
after	O
percutaneous	O
ablation	B:C0547070
of	O
functional	O
adrenal	O
adenomas	I:C0206667
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
establish	O
the	O
suitability	O
of	O
the	O
apparent	O
diffusion	O
coefficient	O
(	O
ADC	O
)	O
as	O
a	O
parameter	O
for	O
evaluating	O
early	O
treatment	O
response	I:C0521982
after	O
percutaneous	O
ablation	O
of	O
functional	O
adrenal	B:C0206667
adenomas	I:C0206667
.	O

Seventeen	O
adult	O
patients	O
with	O
functioning	O
adrenal	B:C0206667
adenomas	I:C0206667
underwent	O
radiofrequency	O
ablation	I:C0850292
.	O

Seventeen	O
adult	O
patients	O
with	O
functioning	O
adrenal	O
adenomas	I:C0206667
underwent	O
radiofrequency	B:C0850292
ablation	I:C0850292
.	O

Serum	B:C0229671
hormone	O
levels	O
were	O
analyzed	O
before	O
and	O
up	O
to	O
6	O
months	O
after	O
ablation	O
.	O

Serum	O
hormone	B:C0019932
levels	O
were	O
analyzed	O
before	O
and	O
up	O
to	O
6	O
months	O
after	O
ablation	O
.	O

Serum	O
hormone	O
levels	O
were	O
analyzed	B:C0936012
before	O
and	O
up	O
to	O
6	O
months	O
after	O
ablation	O
.	O

Serum	O
hormone	O
levels	O
were	O
analyzed	O
before	O
and	O
up	O
to	O
6	O
months	O
after	O
ablation	B:C0547070
.	O

MRI	B:C0024485
findings	O
(	O
nodule	O
size	I:C0449457
in	O
cm	O
,	O
signal	O
intensity	O
index	O
,	O
ADC	O
maps	O
,	O
and	O
nodule	O
-	O
to	O
-	O
muscle	O
ADC	O
ratio	O
)	O
were	O
analyzed	O
before	O
and	O
up	O
to	O
30	O
days	O
after	O
ablation	O
.	O

MRI	O
findings	B:C0243095
(	O
nodule	O
size	I:C0449457
in	O
cm	O
,	O
signal	O
intensity	O
index	O
,	O
ADC	O
maps	O
,	O
and	O
nodule	O
-	O
to	O
-	O
muscle	O
ADC	O
ratio	O
)	O
were	O
analyzed	O
before	O
and	O
up	O
to	O
30	O
days	O
after	O
ablation	O
.	O

MRI	O
findings	O
(	O
nodule	B:C0449457
size	I:C0449457
in	O
cm	O
,	O
signal	O
intensity	O
index	O
,	O
ADC	O
maps	O
,	O
and	O
nodule	O
-	O
to	O
-	O
muscle	O
ADC	O
ratio	O
)	O
were	O
analyzed	O
before	O
and	O
up	O
to	O
30	O
days	O
after	O
ablation	O
.	O

MRI	O
findings	O
(	O
nodule	O
size	I:C0449457
in	O
cm	O
,	O
signal	O
intensity	O
index	O
,	O
ADC	O
maps	O
,	O
and	O
nodule	O
-	O
to	O
-	O
muscle	O
ADC	O
ratio	O
)	O
were	O
analyzed	B:C0936012
before	O
and	O
up	O
to	O
30	O
days	O
after	O
ablation	O
.	O

MRI	O
findings	O
(	O
nodule	O
size	I:C0449457
in	O
cm	O
,	O
signal	O
intensity	O
index	O
,	O
ADC	O
maps	O
,	O
and	O
nodule	O
-	O
to	O
-	O
muscle	O
ADC	O
ratio	O
)	O
were	O
analyzed	O
before	O
and	O
up	O
to	O
30	O
days	O
after	O
ablation	B:C0547070
.	O

A	O
consensus	O
review	O
of	O
all	O
scans	B:C0441633
was	O
performed	O
by	O
two	O
attending	O
abdominal	O
imaging	I:C0260194
radiologists	I:C0260194
.	O

A	O
consensus	O
review	O
of	O
all	O
scans	O
was	O
performed	O
by	O
two	O
attending	O
abdominal	B:C0260194
imaging	I:C0260194
radiologists	I:C0260194
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	B:C0229671
hormone	O
levels	O
normalized	O
and	O
no	O
contrast	O
enhancement	O
of	O
the	O
adrenal	O
lesion	O
was	O
seen	O
on	O
follow	O
-	I:C1522577
up	I:C1522577
MRI	O
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	O
hormone	B:C0019932
levels	O
normalized	O
and	O
no	O
contrast	O
enhancement	O
of	O
the	O
adrenal	O
lesion	O
was	O
seen	O
on	O
follow	O
-	I:C1522577
up	I:C1522577
MRI	O
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	O
hormone	O
levels	O
normalized	B:C1882115
and	O
no	O
contrast	O
enhancement	O
of	O
the	O
adrenal	O
lesion	O
was	O
seen	O
on	O
follow	O
-	I:C1522577
up	I:C1522577
MRI	O
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	O
hormone	O
levels	O
normalized	O
and	O
no	B:C1513916
contrast	O
enhancement	O
of	O
the	O
adrenal	O
lesion	O
was	O
seen	O
on	O
follow	O
-	I:C1522577
up	I:C1522577
MRI	O
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	O
hormone	O
levels	O
normalized	O
and	O
no	O
contrast	O
enhancement	O
of	O
the	O
adrenal	B:C0001625
lesion	O
was	O
seen	O
on	O
follow	O
-	I:C1522577
up	I:C1522577
MRI	O
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	O
hormone	O
levels	O
normalized	O
and	O
no	O
contrast	O
enhancement	O
of	O
the	O
adrenal	O
lesion	B:C0221198
was	O
seen	O
on	O
follow	O
-	I:C1522577
up	I:C1522577
MRI	O
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	O
hormone	O
levels	O
normalized	O
and	O
no	O
contrast	O
enhancement	O
of	O
the	O
adrenal	O
lesion	O
was	O
seen	O
on	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
MRI	O
.	O

The	O
procedure	O
was	O
considered	O
successful	O
if	O
serum	O
hormone	O
levels	O
normalized	O
and	O
no	O
contrast	O
enhancement	O
of	O
the	O
adrenal	O
lesion	O
was	O
seen	O
on	O
follow	O
-	I:C1522577
up	I:C1522577
MRI	B:C0024485
.	O

Of	O
17	O
patients	O
who	O
underwent	O
radiofrequency	B:C0850292
ablation	I:C0850292
,	O
complete	O
response	I:C4050094
was	O
achieved	O
in	O
16	O
patients	O
with	O
partial	O
response	I:C1521726
in	O
one	O
patient	O
.	O

Of	O
17	O
patients	O
who	O
underwent	O
radiofrequency	O
ablation	I:C0850292
,	O
complete	B:C4050094
response	I:C4050094
was	O
achieved	O
in	O
16	O
patients	O
with	O
partial	O
response	I:C1521726
in	O
one	O
patient	O
.	O

Of	O
17	O
patients	O
who	O
underwent	O
radiofrequency	O
ablation	I:C0850292
,	O
complete	O
response	I:C4050094
was	O
achieved	O
in	O
16	O
patients	O
with	O
partial	B:C1521726
response	I:C1521726
in	O
one	O
patient	O
.	O

This	O
prospective	B:C0033522
study	I:C0033522
suggests	O
that	O
apparent	O
diffusion	O
coefficient	O
values	O
may	O
help	O
radiologists	O
monitor	O
early	O
treatment	O
response	I:C0521982
after	O
CT	O
-	O
guided	O
radiofrequency	O
ablation	I:C0850292
of	O
functioning	O
adrenal	O
adenomas	I:C0206667
.	O

This	O
prospective	O
study	I:C0033522
suggests	O
that	O
apparent	O
diffusion	O
coefficient	O
values	O
may	O
help	O
radiologists	B:C0260194
monitor	O
early	O
treatment	O
response	I:C0521982
after	O
CT	O
-	O
guided	O
radiofrequency	O
ablation	I:C0850292
of	O
functioning	O
adrenal	O
adenomas	I:C0206667
.	O

This	O
prospective	O
study	I:C0033522
suggests	O
that	O
apparent	O
diffusion	O
coefficient	O
values	O
may	O
help	O
radiologists	O
monitor	B:C0030695
early	O
treatment	O
response	I:C0521982
after	O
CT	O
-	O
guided	O
radiofrequency	O
ablation	I:C0850292
of	O
functioning	O
adrenal	O
adenomas	I:C0206667
.	O

This	O
prospective	O
study	I:C0033522
suggests	O
that	O
apparent	O
diffusion	O
coefficient	O
values	O
may	O
help	O
radiologists	O
monitor	O
early	O
treatment	B:C0521982
response	I:C0521982
after	O
CT	O
-	O
guided	O
radiofrequency	O
ablation	I:C0850292
of	O
functioning	O
adrenal	O
adenomas	I:C0206667
.	O

This	O
prospective	O
study	I:C0033522
suggests	O
that	O
apparent	O
diffusion	O
coefficient	O
values	O
may	O
help	O
radiologists	O
monitor	O
early	O
treatment	O
response	I:C0521982
after	O
CT	B:C0040405
-	O
guided	O
radiofrequency	O
ablation	I:C0850292
of	O
functioning	O
adrenal	O
adenomas	I:C0206667
.	O

This	O
prospective	O
study	I:C0033522
suggests	O
that	O
apparent	O
diffusion	O
coefficient	O
values	O
may	O
help	O
radiologists	O
monitor	O
early	O
treatment	O
response	I:C0521982
after	O
CT	O
-	O
guided	O
radiofrequency	B:C0850292
ablation	I:C0850292
of	O
functioning	O
adrenal	O
adenomas	I:C0206667
.	O

This	O
prospective	O
study	I:C0033522
suggests	O
that	O
apparent	O
diffusion	O
coefficient	O
values	O
may	O
help	O
radiologists	O
monitor	O
early	O
treatment	O
response	I:C0521982
after	O
CT	O
-	O
guided	O
radiofrequency	O
ablation	I:C0850292
of	O
functioning	O
adrenal	B:C0206667
adenomas	I:C0206667
.	O

